CLEC1B and neoplasm: Based on this knowledge, a synthetic CLEC-2-blocking agent, cobalt hematoporphyrin, has been developed which inhibits CLEC-2 mediated platelet–tumour cell-interaction and curbs haematogenous metastasis in in vivo experiments [195].